表紙
市場調查報告書
商品編碼
1082805

吞嚥障礙管理的全球市場:2022年∼2029年

Global Dysphagia Management Market - 2022-2029

出版日期: | 出版商: DataM Intelligence | 英文 160 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球吞嚥障礙管理的市場調查,彙整市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素的分析,未滿足需求,市場規模的轉變·預測,各種區分·地區/各主要國家的明細,競爭環境,主要企業簡介等資訊。

目錄

第1章 調查手法·調查範圍

第2章 市場定義和概要

第3章 摘要整理

第4章 市場動態

  • 影響市場的要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 產業分析

  • 供應鏈分析
  • 價格分析
  • 未滿足需求

第6章 COVID-19分析

  • COVID-19:對市場的影響分析
  • COVID-19風暴中的價格動態
  • 供需頻譜
  • 政府在COVID-19疫情下的市場相關措施
  • 製造商的策略性舉措
  • 總論

第7章 市場分析:各產品類型

  • 藥物
    • 奧美拉唑(Prilosec)
    • 埃索美拉唑(耐信)
    • 蘭索拉唑(前酸)
    • 雷貝拉唑(AcipHex)
    • 其他
  • 營養管
    • 鼻胃管
    • PEG管
    • 其他
  • 營養解決方案
    • 增稠劑
    • 飲料
    • 食物泥
    • 其他

第8章 市場分析:各適應症

  • 口腔咽吞嚥障礙
  • 食道吞嚥障礙

第9章 市場分析:各流通管道

  • 醫院藥局
  • 零售藥局
  • 專門診所
  • 藥妝店
  • 其他

第10章 市場分析:各地區

  • 北美
  • 歐洲
  • 南美
  • 亞太地區
  • 中東·非洲

第11章 競爭情形

  • 主要的展開·策略
  • 企業佔有率分析
  • 產品基準
  • 關注的主要企業清單

第12章 企業簡介

  • Allergan, Inc.
  • AstraZeneca Pharmaceuticals LP
  • Takeda Pharmaceuticals America, Inc.
  • Eisai R&D Management Co., Ltd
  • Degania Silicone ltd
  • Vygon
  • Cook Medical
  • Cargill, Incorporated
  • CP Kelco U.S., Inc.
  • Ingredion

第13章 全球吞嚥障礙管理市場:DataM

目錄
Product Code: DMPH5237

Market Overview

The global dysphagia management market size was valued US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).

Dysphagia is a condition that causes difficulties swallowing food or drinks. Large bits of food, little chewing, dry mouth, medicines, or eating extremely hot food are all causes of the condition. Food texture modifying products and other goods such as tubes are used to help with dysphagia management. Although some medications are available to treat dysphagia, they are not effective for all illnesses.

Market Dynamics

Advancement in the devices for the diagnosis of Dysphagia is expected to drive market growth.

Swallowscope is a mobile health-based wearable gadget that uses the swallowing sound to statistically assess swallowing abilities. It is appropriate to monitor swallowing activities because swallowing sounds may be caught constantly and throughout daily activities with no intervention. Continuous monitoring provides a higher possibility of capturing aspirations and dangerous swallow patterns. Moreover, Ultrasonography is becoming more popular as a non-invasive and radiation-free tool for evaluating swallowing function. For instance, Ultrasonographic techniques such as B-mode dynamic scanning, pixel analysis, M-mode, Doppler, 3D reconstruction, and sonoelastography have been used to assess oropharyngeal structural movement. Thus, the market is expected to drive in the forecast period from the above statements.

Restraint:

Dysphagia drugs and tubes have side effects and cause discomfort. For instance, the use of nasogastric tubes or PEG tubes might induce throat discomfort, abdominal cramping, abdominal swelling, diarrhea, nausea, vomiting, food and drug regurgitation, and difficulties diagnosing the actual reason for dysphagia are some of the factors the market is expected to hamper in the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. The European Society for Swallowing Disorders offers suggestions to help experts in swallowing disorders in their therapeutic work. Patients with oropharyngeal dysphagia are assessed and treated during the COVID-19 pandemic while balancing the danger of oropharyngeal problems with the risk of infection for patients and healthcare professionals involved in their care. Elective, non-urgent assessments are postponed temporarily. Patients are triaged to determine whether a dysphagia assessment is required; an instrumental swallowing assessment is performed only if instrument processing is guaranteed. Clinical assessment has not provided enough diagnostic information for treatment prescription.

Moreover, Oropharyngeal dysphagia assessment and management are high-risk since it is an aerosol-generating technique. It is recommended that personal protective equipment (PPE) be worn. Telepractice is recommended, as well as compensatory therapy. Additionally, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of the economic activities.

Segment Analysis

Hospital Pharmacies segment is expected to hold the largest market share in dysphagia management market

The hospital pharmacies segment is expected to dominate in 2021. The segment is benefitted because, in hospital pharmacies, dysphagia management is utilized to treat dysphagia and avoid aspiration. It could also be an alternative or supplement to other treatments such as thickened drinks with nutritional supplements, diet changes, chest physiotherapy, oxygen therapy, or medicine to improve swallowing function. By strengthening swallow reflexes and preventing aspiration, dysphagia management medicines can minimize the risk of lung infections that cause pneumonia. Thus, the market segment is expected to hold the largest market share in the forecast period from the above statements.

Geographical Analysis

North America region holds the largest market share in the global dysphagia management market

In 2021, North America accounted for the highest revenue share. The increasing prevalence of neurological diseases and disorders, rising geriatric population, well-established infrastructure, technological advancement in the diagnosis of dysphagia and product launches by the market players in the region are some of the factors the market is expected to boost in the forecast period. For instance, In the United States, almost one million people suffer from MS. This new prevalence rate was released in 2019, and it is more than double the previous estimate of 400,000 people in the United States who are impacted. Moreover, Thick & Easy Coffee Sticks were launched by Hormel Health Labs, a manufacturer of health and nutrition products, in July 2019 for persons with dysphagia. Thus, the North American region is expected to hold the largest market share in the forecast period from the above statements.

Competitive Landscape

Major key players in the dysphagia management market are Allergan, Inc. , AstraZeneca Pharmaceuticals LP, Takeda Pharmaceuticals America, Inc., Eisai R&D Management Co., Ltd, Degania Silicone ltd, Vygon, Cook Medical, Cargill, Incorporated, CP Kelco U.S., Inc., Ingredion

AstraZeneca Pharmaceuticals LP:

Overview:

AstraZeneca Plc (AstraZeneca) is a biopharmaceutical company that discovers, produces and commercializes a wide range of prescription drugs. It focuses on therapy areas such as respiratory, cardiovascular, renal and metabolic diseases; and cancer, besides autoimmune, infection and neurological diseases. The company's product portfolio includes biologics, prescription pharmaceuticals and vaccines. AstraZeneca sells its products through wholly-owned local marketing companies, distributors and local representative offices. The company markets its products to primary care and specialty care physicians. It operates in over 100 countries, and its innovative medicines are used by millions of patients worldwide.

­Product Portfolio:

PRILOSEC (omeprazole magnesium): Omeprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as heartburn, difficulty swallowing, and cough.

Why Purchase the Report?

Visualize the composition of the dysphagia management market segmentation by product type, indication, distribution channel, and region highlighting the key commercial assets and players.

Identify commercial opportunities in dysphagia management market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of dysphagia management market- level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global dysphagia management market report would provide an access to an approx. 45+market data table, 40+figures and 160pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Product Type
  • 3.2. Market Snippet by Indication
  • 3.3. Market Snippet by Distribution channel
  • 3.4. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Advancement in the devices for the diagnosis of Dysphagia is expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. Side effects of dysphagia drugs are expected to hamper the market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Supply Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Unmet Needs

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type Segment
  • 7.2. Drugs*
    • 7.2.1. Omeprazole (Prilosec)
    • 7.2.2. Esomeprazole (Nexium)
    • 7.2.3. Lansoprazole (Prevacid)
    • 7.2.4. Rabeprazole (AcipHex)
    • 7.2.5. Others
    • 7.2.6. Introduction
    • 7.2.7. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Feeding Tubes
    • 7.3.1. Naso-Gastric Tubes
    • 7.3.2. PEG Tubes
    • 7.3.3. Others
  • 7.4. Nutritional Solutions
    • 7.4.1. Thickeners
    • 7.4.2. Beverages
    • 7.4.3. Puree
    • 7.4.4. Others

8. By Indication

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 8.1.2. Market Attractiveness Index, By Indication Segment
  • 8.2. Oropharangeal Dysphagia*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Esophageal Dysphagia

9. By Distribution Channel

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.1.2. Market Attractiveness Index, By Distribution Channel Segment
  • 9.2. Hospital Pharmacies*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Retail Pharmacies
  • 9.4. Specialty Clinics
  • 9.5. Drug Stores
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. Allergan, Inc.*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. AstraZeneca Pharmaceuticals LP
  • 12.3. Takeda Pharmaceuticals America, Inc.
  • 12.4. Eisai R&D Management Co., Ltd
  • 12.5. Degania Silicone ltd
  • 12.6. Vygon
  • 12.7. Cook Medical
  • 12.8. Cargill, Incorporated
  • 12.9. CP Kelco U.S., Inc.
  • 12.10. Ingredion

LIST NOT EXHAUSTIVE

13. Global Dysphagia Management Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Applications
  • 13.3. Contact Us